• news.cision.com/
  • Bioservo AB/
  • Bioservo Technologies (public) appoints Officine Ortopediche Rizzoli S.r.l. as distributor for Carbonhand® in Italy

Bioservo Technologies (public) appoints Officine Ortopediche Rizzoli S.r.l. as distributor for Carbonhand® in Italy

Report this content

Bioservo has entered an exclusive distribution agreement for Carbonhand® with Italian Officine Ortopediche Rizzoli. Officine Ortopediche Rizzoli is a well-established company that provides orthopedic and rehabilitation solutions since 1896. In 2016 Officine Ortopediche Rizzoli started a new business unit called “Primacura” that focuses on introducing ground-breaking innovative technology and solutions in Italy. Carbonhand® will be added to the portfolio of the “Primacura” range.

Bioservo has entered an exclusive distribution agreement for Carbonhand® with Italian Officine Ortopediche Rizzoli. Officine Ortopediche Rizzoli is a well-established company that provides orthopedic and rehabilitation solutions since 1896. In 2016 Officine Ortopediche Rizzoli started a new business unit called “Primacura” that focuses on introducing ground-breaking innovative technology and solutions in Italy. Carbonhand® will be added to the portfolio of the “Primacura” range.

Alessandro Maggi, Managing Director at Officine Ortopediche Rizzoli comments: “We see an increasing demand for innovative solutions that improve quality of life. Italy is on the fore-front of the development of robotic innovations and we see a lot of interest in Carbonhand®. We are looking forward to working with this fantastic product.”

"Officine Ortopediche Rizzoli is an ideal partner with a complementary product portfolio and extensive network in Italy, especially their new focus on innovative technology makes them a perfect partner. They have the infrastructure and experience needed to introduce Carbonhand® in Italy. From a company perspective, I see a clear value creation in using established dedicated distributors for key markets within our Healthcare segment, not only is this a fast track for reaching patients in need for assistance, it also enables us to focus on the Industry segment with own personnel, commented Petter Bäckgren, CEO Bioservo Technologies.

Carbonhand® is a grip strengthening medical device that has been developed using Bioservo’s patented SEM™ technology. It is designed for users with an impaired hand function. Carbonhand® is part of the next generation of medical devices that combine the best of two worlds – medical research and ground-breaking bionic technology. It is designed to be a wearable which is intuitive and easy to use. It supports the wearer when there is a need for extra strength and endurance in the hand.

Bioservo Technologies AB Press Contacts

Petter Bäckgren

CEO                                                                                                      

Tel.: +46 (0)70 555 69 97

petter.backgren@bioservo.com  

Anett Grusser-Pettersson  

International Business Development

Tel.: +46 (0) 70 795 34 81                                                  

anett.pettersson@bioservo.com

Bioservo Technologies in brief

Bioservo Technologies (publ) is a technology and development company that combines medical science with modern robotics. The company holds a leading global position within soft exoskeleton technology – wearable non-invasive devices – for people in need of extra power to optimise the body’s endurance and performance, or for people with reduced muscle strength.

After many years of research and development, Bioservo Technologies is now focused on a commercialisation of the company’s products and patented technologies. The gloves are well-suited to medical rehabilitation, and to preventive use by healthcare professionals. The company has, for example, signed strategic partnership agreements with several multinational companies within the automotive and aerospace industry as well as companies active in construction/ infrastructure.

Bioservo Technologies was founded in 2006 through a collaboration between researchers at the Royal Institute of Technology and doctors at Karolinska University Hospital in Stockholm. Bioservo Technologies is a Swedish public limited company with its headquarters and operations based in Kista, north of Stockholm.

For more information, please visit www.bioservo.com

Subscribe